1M6MYTD1Y5YMAX
Loading quotes...
Forecast
| Buy |
6 |
| Hold |
2 |
| Sell |
0 |
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
| (EUR) | Jun 2026 | |
|---|---|---|
| Revenue | 0 | - |
| Gross profit | 0 | - |
| Net profit | -2.14T | 41,760,245.15% |
| EBITDA | -2.29T | 44,749,814.85% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €5.73M |
Number of shares | 12.81M |
52-week high/low | €14.83 - €0.23 |
| Dividends | No |
Beta | 0.49 |
P/E ratio | -0.07 |
PEG ratio | 0.00 |
P/B ratio | 0.00 |
P/S ratio | 0.00 |
Company profile
| Name | Reviva Pharmaceuticals Holdings Inc |
| CEO | Laxminarayan Bhat |
| Employees | 14 |
Discover assets
Shareholders of Reviva Pharmaceuticals Holdings Inc also invest in the following assets
